Dyadic Announces Sale of Equity Interest in Alphazyme
January 19, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
January 13, 2023 13:07 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
BioGX Launches 'pixl™' Portable qPCR Platform Ex-US With Expanded Test Menu for Infectious Diseases
December 08, 2022 14:00 ET
|
BioGX Inc.
BIRMINGHAM, Ala., Dec. 08, 2022 (GLOBE NEWSWIRE) -- BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced the Ex-US commercial release of its portable pixl™ qPCR...
Point-of-Care Diagnostics Market Worth $82.74 Billion by 2029 - Exclusive Report by Meticulous Research®
November 22, 2022 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, COVID-19, TB, HAI,...
Global Molecular Diagnostics Market is projected to grow at a CAGR of 7.28% by 2032: Visiongain Reports Ltd
November 17, 2022 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Molecular Diagnostics Market 2022-2032. It includes profiles of Molecular Diagnostics Market and Forecasts Market Segment by Market Segment by Type...
Persbericht Biocartis Group NV: Biocartis lanceert een aandelenuitgifte met voorkeurrecht (met extralegale voorkeurrechten voor bestaande aandeelhouders) van maximaal 33.476.932 aangeboden aandelen,ten bedrage van maximaal EUR 25.107.699,00
November 16, 2022 01:00 ET
|
Biocartis NV
ADVERTENTIE PERSBERICHT: VOORKENNIS / GEREGLEMENTEERDE INFORMATIE16 november 2022, 07:00 CET Biocartis lanceert een aandelenuitgifte met voorkeurrecht (met extralegale voorkeurrechten voor bestaande...
Press release Biocartis Group NV: Biocartis launches a rights offering (with extra-legal preferential rights for existing shareholders) of a maximum of 33,476,932 offered shares, amounting to a maximum of EUR 25,107,699.00
November 16, 2022 01:00 ET
|
Biocartis NV
ADVERTISEMENT PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 16 November 2022, 07:00 CET Biocartis launches a rights offering (with extra-legal preferential rights for existing...
In-Vitro Diagnostics Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 15, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The global in-vitro diagnostics market size is expected to witness remarkable growth during the forecast period, attributed to growing incidence of...
Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications
November 07, 2022 14:32 ET
|
NuProbe USA Inc
Hercules, Calif. and Houston, Texas, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and...
Molecular Diagnostics Market Worth $25.59 Billion by 2029 - Exclusive Report by Meticulous Research®
November 02, 2022 10:42 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 02, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab,...